R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL
Status:
Withdrawn
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of chemotherapy alone and combined modality therapy in the
treatment of localized CD20 (+) diffuse large B-cell lymphoma